The biopharma company achieved $1 billion in revenue for the first time in its September-ended quarter. More recently, it achieved a more significant milestone when it turned prof ...

Alvotech and Dr. Reddy's will co-develop a biosimilar to Keytruda, aiming to expand global access to cancer treatment alternatives.

As a chemist at Florida State, he pioneered techniques used in the large-scale production of Taxol, a blockbuster anti-cancer agent.

Cornell researchers have developed a new way to safely heat up specific areas inside the body by using biodegradable polymers ...

The doctor is in — the mailbox, that is. You can now do self-administered tests for everything from thyroid function to HIV ...

Getting enough fiber is crucial for optimal health, yet more than 90% of Americans don’t. Federal dietary guidelines ...

Within weeks of treating patients with CER-1236, the company hopes to start learning about its safety profile and gauge efficacy markers.

Iopofosine-131 received FDA breakthrough status for relapsed or refractory Waldenstrom macroglobulinemia, showing strong ...

For US adult cancer survivors with a new alcohol use disorder diagnosis, the 1-year cumulative incidence of treatment initiation was 14.3%.

In the late 2010s, Novo Nordisk shelved a weekly obesity treatment that targeted three hormones at once, though it caused notable weight loss in mice ...

An AI-enabled handheld ESS device, which differentiates between benign and malignant tissue, helps PCPs improve their ...

The US Food and Drug Administration (FDA) has expanded the approved use of Nubeqa (darolutamide) for patients with metastatic castration-sensitive prostate cancer (mCSPC). The drug is now approved for ...